This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. slid 4.6% to $1.85 on what proved to be an all-around rough trading session for the stock market, with the Dow Jones Industrial Average remaining mostly unchanged at 44,938.31 and the NASDAQ Composite Index falling 0.7% to 21,172.86.
The stock's fall snapped a three-day winning streak.
Inovio Pharmaceuticals Inc. closed 76.2% below its 52-week high of $7.77, which the company achieved on August 21st.
The stock underperformed when compared to some of its competitors, as Johnson & Johnson rose 0.6% to $178.84, Statera Biopharma Inc. remained unchanged, and Pfizer Inc. rose 0.24% to $25.38.
Trading volume totaled 1.1 million, compared to the 50-day average of 2.2 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
August 20, 2025 16:33 ET (20:33 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.